Morgan Stanley, Chubb, CVS Health And An ETF Up 19% YTD: CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades', several financial experts gave their opinions on various stocks and ETFs. Bryn Talkington recommended JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) due to its 10% distribution yield. Josh Brown suggested Chubb Limited (CB) following its better-than-expected Q2 results. Sarat Sethi defended Morgan Stanley (MS) which was beaten down on Tuesday, despite its strong Q2 results. Stephanie Link recommended CVS Health Corporation (CVS) which she considers undervalued and highlighted its Q2 sales increase of 10.3% YoY.
August 09, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Chubb Limited was recommended following its better-than-expected Q2 results.
The company's strong Q2 results were highlighted as a positive factor, which could attract investors seeking growth.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
CVS Health Corporation was recommended as undervalued, with its Q2 sales increase of 10.3% YoY highlighted.
The company's strong Q2 sales growth and perceived undervaluation were highlighted as positive factors, which could attract value investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
POSITIVE IMPACT
JPMorgan Nasdaq Equity Premium Income ETF was recommended due to its 10% distribution yield.
The ETF's high distribution yield was highlighted as a positive factor, which could attract investors seeking income.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75
NEUTRAL IMPACT
Morgan Stanley was defended despite being beaten down on Tuesday, with its strong Q2 results highlighted.
Despite the recent drop in price, the company's strong Q2 results were highlighted as a positive factor, which could attract investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75